EMA Withdrawn: Ioa (nomegestrol acetate;estradiol) — Organon N.V.

View source ↗

Summary

EMA has withdrawn the contraceptive product Ioa (nomegestrol acetate and estradiol) from Organon N.V.'s portfolio.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Contraception

Drugs mentioned

• Ioa (nomegestrol acetate; estradiol)

Snippet

Status: Withdrawn. Therapeutic area: Contraception. MAH: Organon N.V.. Decision date: 16/01/2014